Excretion of mephedrone and its phase I metabolites in urine after a controlled intranasal administration to healthy human volunteers.

Czerwinska, Joanna; Parkin, Mark C; George, Claire; Kicman, Andrew T; Dargan, Paul I; Abbate, Vincenzo

Czerwinska, Joanna; Parkin, Mark C; George, Claire; Kicman, Andrew T; Dargan, Paul I; Abbate, Vincenzo.

Afiliação

Czerwinska J; Department of Analytical, Environmental and Forensic Sciences, King's College London, London, UK.
Parkin MC; Department of Analytical, Environmental and Forensic Sciences, King's College London, London, UK.
George C; Toxicology Department, Eurofins Forensic Services, Feltham, UK.
Kicman AT; Toxicology Department, Abbott Toxicology Ltd, Alere Toxicology (now part of Abbott), Oxfordshire, UK.
Dargan PI; Department of Analytical, Environmental and Forensic Sciences, King's College London, London, UK.
Abbate V; Clinical Toxicology, Faculty of Life Sciences and Medicine, King's College London, London, UK.

Drug Test Anal ; 14(4): 741-746, 2022 Apr.

Article em En | MEDLINE | ID: mdl-34984836

Assuntos

Estimulantes do Sistema Nervoso Central; Metanfetamina; Administração Intranasal; Estimulantes do Sistema Nervoso Central/urina; Voluntários Saudáveis; Humanos; Masculino; Metanfetamina/análogos & derivados; Espectrometria de Massas em Tandem/métodos

Palavras-chave

intranasal administration; mephedrone; metabolites; urine

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Estimulantes do Sistema Nervoso Central / Metanfetamina Limite: Humans / Male Idioma: En Revista: Drug Test Anal Assunto da revista: FARMACOLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google